Vivek Kumar Pandey

About

I am a Scientist in the Department of Physical Medicine and Rehabilitation at the University of Kentucky, where I conduct translational research investigating the interplay between spinal cord injury and diabetes, particularly their combined contribution to autonomic dysfunction in human patients, and attempt to understand the plausible mechanisms using rodent models. Previously, as a postdoctoral scholar at the University of Kentucky, my research focused on diabetes-mediated cardiac remodeling, neurodegenration, and aging.

I earned my Ph.D. in Biological Sciences from AcSIR–CSIR-IITR, with a specialization in Biochemistry, Biotechnology, and Toxicology. My doctoral research explored the role of ER stress in diabetic liver injury and the involvement of FoxO protein modifications in hepatic cancer cell apoptosis. I also have industry experience as a Research Scientist at Accutest Biologics Pvt. Ltd., where I contributed to preclinical evaluation of biosimilars for their anti-diabetic and anti-cancer potential using various cell-based and molecular techniques.

Employment

• University of Kentucky Scientist III
  2026 - Present
• University of Kentucky Scientist II
  2025 - 2026
• University of Kentucky Postdoctoral Scholar
  2025 - 2025
• University of Kentucky Postdoctoral Scholar
  2020 - 2025
• Accutest Biologics Pvt Ltd Research Scientist
  2019 - 2020
• Indian Institute of Toxicology Research CSIR Senior Research Fellow
  2016 - 2019
• Indian Institute of Toxicology Research CSIR Junior Research Fellow
  2014 - 2016
• Indian Institute of Toxicology Research CSIR Project Fellow
  2014 - 2014

Education

• University of Kentucky Postdoc Mentoring Training
  2025 - 2025
• University of Kentucky Fundamentals of Funding training
  2024 - 2024
• Brahmanand PG College, CSJMU M.Sc.
  2010 - 2012

Projects & Funding

Projects & funding information is unavailable.

Publications (26)

• Spinal cord neuromodulation for autonomic recovery following spinal cord injury: a scoping review
  Journal of NeuroEngineering and Rehabilitation 2026 DOI: 10.1186/s12984-026-02032-4
  +Save
• Abstract DP269: Reduced Pancreatic Secretion of Amyloid-Forming Amylin Preserves Telomere Integrity and Mitigates Ischemic Stroke
  Stroke 2026 DOI: 10.1161/str.57.suppl_1.dp269
  +Save
• Endoplasmic reticulum – Mitochondrial crosstalk at MAMs: Shaping cancer metabolism and cell death decisions
  Cell Death 2026 DOI: 10.1016/j.celld.2026.100002
  +Save
• The PERK paradox in aging: how ER stress shapes senescence and neurodegeneration
  GeroScience 2026 DOI: 10.1007/s11357-026-02430-5
  +Save
• Cardiac remodelling, recognition memory deficits and accelerated ageing in a rat model of gestational diabetes
  Diabetologia 2025 DOI: 10.1007/s00125-025-06421-7
  +Save
• Preclinical and Clinical Trials of Plant‐derived Nanoparticles in Different Cancers
  Plant‐derived Anticancer Drugs 2025 DOI: 10.1002/9781394300594.CH14
  +Save
• When Cells Speak in Many Languages: The Evolving Story of Cellular Signaling
  Journal of Cellular Signaling 2025 DOI: 10.33696/SIGNALING.6.146
  +Save
• O-GlcNAcylation underlies the activation of sodium-glucose cotransporter 1 in diabetic hearts
  Circulation Research 2024 DOI: 10.1161/RES.135.SUPPL_1.TU072
  +Save
• Nedd4-2 Inactivation Underlies The Increase In Cardiac Sodium-dependent Glucose Cotransporter-1 In Diabetic Hearts
  Circulation Research 2023 DOI: 10.1161/RES.133.SUPPL_1.P1162
  +Save
• The Emerging Role of Biosensors in the Identification, Characterization, and use of Natural Bioactive Compounds
  Recent Advances in Biosensor Technology 2023 DOI: 10.2174/9789815136418123020005
  +Save